All Articles Tagged With: "Breast Cancer"
Articles
Jury Finds Woman’s Breast Cancer Not Caused by Prempro
Breaking a five-case losing streak for Pfizer, Inc., a Philadelphia jury ruled late last week in favor of the drug company and its subsidiary, Wyeth, in a Prempro breast cancer lawsuit. While the jury did find that the company failed to adequately warn about the risk of breast cancer from Prempro, the plaintiff failed [...]
Prempro Lawsuit Results in $9.5M Award for Breast Cancer Survivor
In yet another loss for Pfizer’s Wyeth unit involving side effects of Prempro, a Philadelphia jury awarded $9.45 million this week to an Alabama woman who said that the hormone replacement therapy caused her to develop breast cancer.
Tamoxifen Side Effects Can Hamper Memory, Cognitive Ability: Study
The results of a new study suggest that side effects of tamoxifen, a breast cancer drug, can lead to decreased cognitive abilities and memory loss.
Paxil and Tamoxifen May Cause Breast Cancer Relapse or Death: Study
Canadian researchers are reporting that the antidepressant Paxil may interfere with breast cancer drug treatments, increasing the risk of relapse and death in breast cancer survivors.
Prempro Verdict for Punitive Damages Reduced by Judge
A Pennsylvania judge has slashed a jury’s $78.7 million award in a Prempro breast cancer lawsuit, saying that the punitive damage portion of the verdict was excessive.
Hormone Replacement Therapy Lawsuits Reinstated on Appeal
More than 100 hormone replacement therapy lawsuits filed by women who developed breast cancer after using Prempro and other drugs have been reinstated by a federal appeals court, which ruled that the cases were wrongly thrown out by a lower court in 2008.
23 Hormone Replacement Therapy Breast Cancer Lawsuits Dismissed
A New York judge has dismissed 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer, saying that the risk of developing breast cancer from the drugs was well known and that the plaintiffs failed to file their lawsuits within the three-year statute of limitations in New York.
Use of Anthracycline Breast Cancer Chemo Drugs Linked to Risks: Study
Researchers indicate that preliminary findings of an ongoing study suggest that health risks associated with a class of older chemotherapy drugs, known as anthracyclines, may outweigh the benefits provide for breast cancer patients, since alternatives are available.
Prempro Punitive Damage Awards Totaling $103M Returned by Two Juries
A Philadelphia jury hit subsidiaries of Pfizer, Inc. with $28 million in punitive damages on Monday in a lawsuit over Prempro hormone replacement therapy filed by Donna Kendall. Following the award, the Court unsealed a prior Prempro punitive damage award issued for $75 million in a similar case decided by another Philadelphia jury last [...]
Another Prempro Trial Results in Multi-Million Dollar Verdict for Breast Cancer
A Philadelphia jury has awarded an Illinois woman $6.3 million in compensatory damages in a lawsuit over Prempro and Provera hormone replacement therapy (HRT) drugs, which the plaintiff alleged was responsible for her development of breast cancer. The case will now enter the punitive damages phase of the trial, to determine whether more money [...]
